title: Hepatitis C identification and management by family physicians.
abstract: OBJECTIVE
  Many people with hepatitis C receive all or most of their care from primary care physicians, yet little information exists about the practice patterns, knowledge, and beliefs and attitudes of family physicians related to hepatitis C.
  
  
  METHODS
  We mailed a written survey to a random sample of active members of the American Academy of Family Physicians.
  
  
  RESULTS
  Nearly all respondents (94%) reported at least one patient with hepatitis C in their practice, and 66% had diagnosed at least one new case of hepatitis C in the past year. While most respondents (85%) correctly identified common hepatitis C risk factors, only 63% reported routinely asking patients about those risk factors. Respondents (74%) preferred to involve specialists in the care of hepatitis C patients, but half (50%) reported barriers to referral. A small number (5%) of respondents have prescribed antiviral medication within the past year. Most respondents think family physicians should screen (94%), diagnose (98%), and provide general care (69%) for hepatitis C patients.
  
  
  CONCLUSIONS
  Family physicians know how to identify high-risk people and test for hepatitis C. Most prefer to refer patients with hepatitis C to specialists for workup and treatment but report frequent barriers to those referrals.
authors.affiliation: Department of Family Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, 200 Hawkins Drive, 01293-F PFP, Iowa City, IA 52242, USA. elizabeth-c-clark@uiowa.edu
authors.forename: Elizabeth C
authors.initials: EC
authors.lastname: Clark
authors.forename: Barbara P
authors.initials: BP
authors.lastname: Yawn
authors.forename: James M
authors.initials: JM
authors.lastname: Galliher
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Temte
authors.forename: John
authors.initials: J
authors.lastname: Hickner
mesh_terms: D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use; D005194:Family Practice / Q000379:methods / Q000706:statistics & numerical data*; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data; D019538:Health Care Surveys; D007722:Health Knowledge, Attitudes, Practice; D016174:Hepacivirus / Q000276:immunology; D006526:Hepatitis C / Q000097:blood / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic / Q000379:methods / Q000706:statistics & numerical data; D010819:Physician's Role; D017410:Practice Guidelines as Topic; D011364:Professional Practice / Q000706:statistics & numerical data*; D012017:Referral and Consultation / Q000706:statistics & numerical data; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D014481:United States
chemical_list: D000914:Antibodies, Viral; D000998:Antiviral Agents